New Suspected Cases of SARS-like MERS Virus in France

Two new suspected cases of infection with the SARS-like virus MERS which has killed more than 30 people worldwide, mostly in Saudi Arabia, were reported by French medical authorities on Tuesday.

The patients suspected of having contracted the virus are both men who have recently spent time in Saudi Arabia and they have been hospitalised in Tours, a town in the Loire region south of Paris.

Severe Acute Respiratory Syndrome (SARS)
SARS is a viral respiratory disease caused by SARS-associated coronavirus.

France has had two confirmed cases of MERS to date, including one which led to a death in the northern town of Lille last month.

In its most recent update on the virus, the World Health Organisation (WHO) said on June 7 that there had been 55 laboratory-confirmed cases of the virus, 31 of which had resulted in the affected individuals dying.

Previously known as novel coronavirus, the disease was last month renamed Middle East Respiratory Syndrome Coronavirus, or MERS-CoV.

Mystery Behind Similar Deadly SARS Virus
After contracting an infection similar to the deadly SARS virus, a Qatari man is critically ill in a London hospital reported World Health Organisation.

The WHO believes 26 of the 31 people who have died contracted the virus in Saudi Arabia.

The virus is a cousin of Severe Acute Respiratory Syndrome (SARS), which sparked a global scare in 2003 after jumping to humans from animals in Asia and claiming 800 lives.

Four New SARS-like Cases Detected in Saudi Arabia
In Saudi Arabia four more new cases of the deadly coronavirus have been detected, says the health ministry.

Like SARS, MERS appears to cause a lung infection, with patients suffering from a temperature, cough and breathing difficulty.

But it differs in that it also causes rapid kidney failure and the extremely high death rate has caused serious concern among health experts.

Scientists Identify Antibodies That Block Human and Animal SARS Viruses
Scientists have for the first time identified human antibodies that can neutralise different strains of the virus responsible for the outbreaks of severe acute respiratory syndrome (SARS).

Source-AFP